Search Results | Cancer Research | American Association for Cancer Research

1-20 of 28

Sort by

Sort Order Select

Journal Articles

Abstract 178: Multidimensional hydrogel model to benchmark progression of temozolomide-resistant glioblastoma

Viktoriia Kriuchkovskaia, Brendan A. Harley, Rebecca B. Riggins

Cancer Res (2022) 82 (12_Supplement): 178.

DOI: https://doi.org/10.1158/1538-7445.AM2022-178

Published: 15 June 2022

View article

Journal Articles

Abstract 1776: Loss of estrogen receptor alters drug responsiveness and supports a basal-like phenotype in endocrine-resistant HER2+/ER+ breast cancer

Shaymaa Bahnassy, Hillary Stires, Lu Jin, Stanley Tam, Yasmin J. Dunn, Brendan F. Kohrn, Lawrence A. Loeb, Manasi Balachandran, Mircea Podar, Matthew D. McCoy, Robert A. Beckman, Rebecca B. Riggins

Cancer Res (2022) 82 (12_Supplement): 1776.

DOI: https://doi.org/10.1158/1538-7445.AM2022-1776

Published: 15 June 2022

View article

Journal Articles

Abstract 2461: Integrated lifetime and spectral phasor imaging of biomarker expression and metabolism in hormone receptor positive breast cancer models

Belen Torrado, Alexander Vallmitjana, Ayodeji Olukoya, Shaymaa Bahnassy, Hillary Stires, Aaron Rozeboom, Rebecca B. Riggins, Suman Ranjit

Cancer Res (2022) 82 (12_Supplement): 2461.

DOI: https://doi.org/10.1158/1538-7445.AM2022-2461

Published: 15 June 2022

View article

Journal Articles

Abstract 1639: Human immune system mouse model of ER+ metastatic breast cancer

Ayodeji Olukoya, Shaymaa Bahnassy, Nicole S. Spoelstra, Lu Jin, Suman Ranjit, Anthony Elias, Jennifer K. Richer, Rebecca B. Riggins

Cancer Res (2022) 82 (12_Supplement): 1639.

DOI: https://doi.org/10.1158/1538-7445.AM2022-1639

Published: 15 June 2022

View article

Journal Articles

Steroid Hormone Receptor and Infiltrating Immune Cell Status Reveals Therapeutic Vulnerabilities of ESR1-Mutant Breast Cancer

Michelle M. Williams, Nicole S. Spoelstra, Spencer Arnesen, Kathleen I. O'Neill, Jessica L. Christenson, Jordan Reese, Kathleen C. Torkko, Andrew Goodspeed, Emmanuel Rosas, Toru Hanamura, Sharon B. Sams, Zheqi Li, Steffi Oesterreich, Rebecca B. Riggins, Britta M. Jacobsen, Anthony Elias, Jason Gertz, Jennifer K. Richer

Cancer Res (2021) 81 (3): 732–746.

DOI: https://doi.org/10.1158/0008-5472.CAN-20-1200

Published: 01 February 2021

View article

Includes: Supplementary data

Journal Articles

Abstract 3605: The role of androgen receptor in invasive lobular breast carcinoma

Hillary Stires, Rebecca B. Riggins

Cancer Res (2017) 77 (13_Supplement): 3605.

DOI: https://doi.org/10.1158/1538-7445.AM2017-3605

Published: 01 July 2017

View article

Journal Articles

Abstract 4131: ERRβ: Validating a novel target for triple negative breast cancer

Aileen I. Fernandez, Garrett Graham, Balázs Győrffy, Luciane Cavalli, Rebecca B. Riggins

Cancer Res (2017) 77 (13_Supplement): 4131.

DOI: https://doi.org/10.1158/1538-7445.AM2017-4131

Published: 01 July 2017

View article

Journal Articles

Interferon Regulatory Factor-1 Signaling Regulates the Switch between Autophagy and Apoptosis to Determine Breast Cancer Cell Fate

Jessica L. Schwartz-Roberts, Katherine L. Cook, Chun Chen, Ayesha N. Shajahan-Haq, Margaret Axelrod, Anni Wärri, Rebecca B. Riggins, Lu Jin, Bassem R. Haddad, Bhaskar V. Kallakury, William T. Baumann, Robert Clarke

Cancer Res (2015) 75 (6): 1046–1055.

DOI: https://doi.org/10.1158/0008-5472.CAN-14-1851

Published: 12 March 2015

View article

Includes: Supplementary data

Journal Articles

Abstract 3570: Phospho-dependent regulation of ERRγ expression, transcriptional activity, and Tamoxifen resistance in ER+ breast cancer.

Rebecca B. Riggins, Mary M. Heckler, Hemang Thakor, Cara C. Schafer, Salendra Singh, Ye Tian, Yuriy Gusev, Subha Madhavan, Yue Wang

Cancer Res (2013) 73 (8_Supplement): 3570.

DOI: https://doi.org/10.1158/1538-7445.AM2013-3570

Published: 15 April 2013

View article

Journal Articles

Abstract LB-29: Erk-mediated phosphorylation of the orphan nuclear receptor ERRγ regulates receptor stability and contributes to Tamoxifen resistance in ER+ breast cancer

Rebecca B. Riggins, Mary M. Heckler, Cara C. Schafer, Minetta C. Liu

Cancer Res (2011) 71 (8_Supplement): LB-29.

DOI: https://doi.org/10.1158/1538-7445.AM2011-LB-29

Published: 15 April 2011

View article

Journal Articles

Abstract 4857: The role of autophagy in taxane resistant breast cancer models

Nesrin S. Rechache, Rebecca B. Riggins, Ayesha N. Shajahan, Alan Zwart, Robert Clarke

Cancer Res (2010) 70 (8_Supplement): 4857.

DOI: https://doi.org/10.1158/1538-7445.AM10-4857

Published: 15 April 2010

View article

Journal Articles

Abstract 4595: ERK/MAPK regulation of ERRγ in Tamoxifen resistant breast cancer

Mary M. Mazzotta, Minetta C. Liu, Robert Clarke, Rebecca B. Riggins

Cancer Res (2010) 70 (8_Supplement): 4595.

DOI: https://doi.org/10.1158/1538-7445.AM10-4595

Published: 15 April 2010

View article

Journal Articles

Abstract 4600: The role of COUP transcription factors in Tamoxifen resistant breast cancer cells

Omar Z. Maniya, Alan Zwart, Li Chen, Jianhua Xuan, Robert Clarke, Rebecca B. Riggins

Cancer Res (2010) 70 (8_Supplement): 4600.

DOI: https://doi.org/10.1158/1538-7445.AM10-4600

Published: 15 April 2010

View article

Journal Articles

Abstract 2919: XBP1 and the unfolded protein response in antiestrogen resistance in breast cancer

Ayesha N. Shajahan, Rebecca B. Riggins, Alan Zwart, F. Edward Hickman, Robert Clarke

Cancer Res (2010) 70 (8_Supplement): 2919.

DOI: https://doi.org/10.1158/1538-7445.AM10-2919

Published: 15 April 2010

View article

Journal Articles

Abstract 5023: Down-regulating interferon regulatory factor-1 by siRNA promotes endurance to fulvestrant in sensitive breast cancer cells partially via Ras/Raf/MEK/ERK pathway

Yanxia Ning, Rebecca B. Riggins, Ayesha N. Shajahan, Alan Zwart, Robert Clarke

Cancer Res (2010) 70 (8_Supplement): 5023.

DOI: https://doi.org/10.1158/1538-7445.AM10-5023

Published: 15 April 2010

View article

Journal Articles

ERRγ Mediates Tamoxifen Resistance in Novel Models of Invasive Lobular Breast Cancer

Rebecca B. Riggins, Jennifer P-J. Lan, Uwe Klimach, Alan Zwart, Luciane R. Cavalli, Bassem R. Haddad, Li Chen, Ting Gong, Jianhua Xuan, Stephen P. Ethier, Robert Clarke

Cancer Res (2008) 68 (21): 8908–8917.

DOI: https://doi.org/10.1158/0008-5472.CAN-08-2669

Published: 30 October 2008

View article

Includes: Supplementary data

Journal Articles

Breast Cancer Antiestrogen Resistance-3 Expression Regulates Breast Cancer Cell Migration through Promotion of p130^Cas Membrane Localization and Membrane Ruffling

Randy S. Schrecengost, Rebecca B. Riggins, Keena S. Thomas, Michael S. Guerrero, Amy H. Bouton

Cancer Res (2007) 67 (13): 6174–6182.

DOI: https://doi.org/10.1158/0008-5472.CAN-06-3455

Published: 06 July 2007

View article

Journal Articles

Physical and Functional Interactions between Cas and c-Src Induce Tamoxifen Resistance of Breast Cancer Cells through Pathways Involving Epidermal Growth Factor Receptor and Signal Transducer and Activator of Transcription 5b

Rebecca B. Riggins, Keena S. Thomas, Huy Q. Ta, Jie Wen, Rebecca J. Davis, Natasha R. Schuh, Stacey S. Donelan, Katherine A. Owen, Matthew A. Gibson, Margaret A. Shupnik, Corinne M. Silva, Sarah J. Parsons, Robert Clarke, Amy H. Bouton

Cancer Res (2006) 66 (14): 7007–7015.

DOI: https://doi.org/10.1158/0008-5472.CAN-05-3952

Published: 18 July 2006

View article

Journal Articles

Human X box binding protein-1 (XBP-1) induces antiestrogen resistance via deregulation of cell cycle progression and the intrinsic apoptotic pathway

Bianca P. Gomez, Rebecca B. Riggins, Yuelin Zhu, Alan Zwart, Aifen Wang, Robert Clarke

Cancer Res (2006) 66 (8_Supplement): 549.

Published: 15 April 2006

View article

Journal Articles

Activation of NFκB in breast cancer cells

Ruchi Nehra, Rebecca B. Riggins, Alan L. Zwart, Robert Clarke

Cancer Res (2006) 66 (8_Supplement): 860.

Published: 15 April 2006

View article

NARROW

Abstract 178: Multidimensional hydrogel model to benchmark progression of temozolomide-resistant glioblastoma

Abstract 1776: Loss of estrogen receptor alters drug responsiveness and supports a basal-like phenotype in endocrine-resistant HER2+/ER+ breast cancer

Abstract 2461: Integrated lifetime and spectral phasor imaging of biomarker expression and metabolism in hormone receptor positive breast cancer models

Abstract 1639: Human immune system mouse model of ER+ metastatic breast cancer

Steroid Hormone Receptor and Infiltrating Immune Cell Status Reveals Therapeutic Vulnerabilities of ESR1-Mutant Breast Cancer

Abstract 3605: The role of androgen receptor in invasive lobular breast carcinoma

Abstract 4131: ERRβ: Validating a novel target for triple negative breast cancer

Interferon Regulatory Factor-1 Signaling Regulates the Switch between Autophagy and Apoptosis to Determine Breast Cancer Cell Fate

Abstract 3570: Phospho-dependent regulation of ERRγ expression, transcriptional activity, and Tamoxifen resistance in ER+ breast cancer.

Abstract LB-29: Erk-mediated phosphorylation of the orphan nuclear receptor ERRγ regulates receptor stability and contributes to Tamoxifen resistance in ER+ breast cancer

Abstract 4857: The role of autophagy in taxane resistant breast cancer models

Abstract 4595: ERK/MAPK regulation of ERRγ in Tamoxifen resistant breast cancer

Abstract 4600: The role of COUP transcription factors in Tamoxifen resistant breast cancer cells

Abstract 2919: XBP1 and the unfolded protein response in antiestrogen resistance in breast cancer

Abstract 5023: Down-regulating interferon regulatory factor-1 by siRNA promotes endurance to fulvestrant in sensitive breast cancer cells partially via Ras/Raf/MEK/ERK pathway

ERRγ Mediates Tamoxifen Resistance in Novel Models of Invasive Lobular Breast Cancer

Breast Cancer Antiestrogen Resistance-3 Expression Regulates Breast Cancer Cell Migration through Promotion of p130^Cas Membrane Localization and Membrane Ruffling

Physical and Functional Interactions between Cas and c-Src Induce Tamoxifen Resistance of Breast Cancer Cells through Pathways Involving Epidermal Growth Factor Receptor and Signal Transducer and Activator of Transcription 5b

Human X box binding protein-1 (XBP-1) induces antiestrogen resistance via deregulation of cell cycle progression and the intrinsic apoptotic pathway

Activation of NFκB in breast cancer cells

Email alerts

AACR Journals

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only